148 related articles for article (PubMed ID: 22737285)
1. Galectin-1, -3, -7 expressions in congenital and acquired pediatric cholesteatomas compared to external auditory canal skin.
Vander Ghinst M; Remmelink M; Mansbach AL; Hassid S; Choufani G
Clin Exp Otorhinolaryngol; 2012 Jun; 5(2):62-7. PubMed ID: 22737285
[TBL] [Abstract][Full Text] [Related]
2. The levels of retinoid RARbeta receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas.
Simon P; Decaestecker C; Choufani G; Delbrouck C; Danguy A; Salmon I; Zick Y; Kaltner H; Hassid S; Gabius HJ; Kiss R; Darro F
Hear Res; 2001 Jun; 156(1-2):1-9. PubMed ID: 11377877
[TBL] [Abstract][Full Text] [Related]
3. The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.
Sheikholeslam-Zadeh R; Decaestecker C; Delbrouck C; Danguy A; Salmon I; Zick Y; Kaltner H; Hassid S; Gabius HJ; Kiss R; Choufani G
Laryngoscope; 2001 Jun; 111(6):1042-7. PubMed ID: 11404618
[TBL] [Abstract][Full Text] [Related]
4. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
5. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Choufani G; Ghanooni R; Decaestecker C; Delbrouck K; Simon P; Schüring MP; Zick Y; Hassid S; Gabius HJ; Kiss R
Laryngoscope; 2001 Sep; 111(9):1656-62. PubMed ID: 11568623
[TBL] [Abstract][Full Text] [Related]
6. The role of S100A1 in external auditory canal cholesteatoma.
Naim R; Hormann K
Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
[TBL] [Abstract][Full Text] [Related]
8. Differential Protein Expression in Congenital and Acquired Cholesteatomas.
Shin SH; Huang M; Kim SH; Choi JY
PLoS One; 2015; 10(9):e0137011. PubMed ID: 26335306
[TBL] [Abstract][Full Text] [Related]
9. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
11. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
12. Cholesteatoma: a molecular and cellular puzzle.
Albino AP; Kimmelman CP; Parisier SC
Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
[TBL] [Abstract][Full Text] [Related]
13. Differences in dendritic cells in congenital and acquired cholesteatomas.
Frankel S; Berson S; Godwin T; Han JC; Parisier SC
Laryngoscope; 1993 Nov; 103(11 Pt 1):1214-7. PubMed ID: 8231573
[TBL] [Abstract][Full Text] [Related]
14. Study of Angiogenic, Pro-Apoptotic, and Pro-Inflammatory Factors in Congenital and Acquired Cholesteatomas.
Rolesi R; Paciello F; Paludetti G; De Corso E; Sergi B; Fetoni AR
J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623440
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
Park K; Chun YM; Park HJ; Lee YD
Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
[TBL] [Abstract][Full Text] [Related]
16. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
18. Immune cell profile in invasive cholesteatomas: preliminary findings.
Hussein MR; Sayed RH; Abu-Dief EE
Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of congenital cholesteatoma of the middle ear].
Kikuchi M; Yamamoto E; Shinohara S; Shiomi Y; Fujiwara K; Shiomi Y; Watanabe F; Tanabe M
Nihon Jibiinkoka Gakkai Kaiho; 2003 Aug; 106(8):797-807. PubMed ID: 14513775
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
